Literature DB >> 17082763

TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.

Naoya Onohara1, Motohiro Nishida, Ryuji Inoue, Hiroyuki Kobayashi, Hideki Sumimoto, Yoji Sato, Yasuo Mori, Taku Nagao, Hitoshi Kurose.   

Abstract

Angiotensin (Ang) II participates in the pathogenesis of heart failure through induction of cardiac hypertrophy. Ang II-induced hypertrophic growth of cardiomyocytes is mediated by nuclear factor of activated T cells (NFAT), a Ca(2+)-responsive transcriptional factor. It is believed that phospholipase C (PLC)-mediated production of inositol-1,4,5-trisphosphate (IP(3)) is responsible for Ca(2+) increase that is necessary for NFAT activation. However, we demonstrate that PLC-mediated production of diacylglycerol (DAG) but not IP(3) is essential for Ang II-induced NFAT activation in rat cardiac myocytes. NFAT activation and hypertrophic responses by Ang II stimulation required the enhanced frequency of Ca(2+) oscillation triggered by membrane depolarization through activation of DAG-sensitive TRPC channels, which leads to activation of L-type Ca(2+) channel. Patch clamp recordings from single myocytes revealed that Ang II activated DAG-sensitive TRPC-like currents. Among DAG-activating TRPC channels (TRPC3, TRPC6, and TRPC7), the activities of TRPC3 and TRPC6 channels correlated with Ang II-induced NFAT activation and hypertrophic responses. These data suggest that DAG-induced Ca(2+) signaling pathway through TRPC3 and TRPC6 is essential for Ang II-induced NFAT activation and cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082763      PMCID: PMC1636614          DOI: 10.1038/sj.emboj.7601417

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

Review 1.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

Authors:  J D Molkentin; G W Dorn
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons.

Authors:  Patrick Delmas; Nicolas Wanaverbecq; Fe C Abogadie; Mohini Mistry; David A Brown
Journal:  Neuron       Date:  2002-04-11       Impact factor: 17.173

3.  Transient receptor potential channels regulate myogenic tone of resistance arteries.

Authors:  Donald G Welsh; Anthony D Morielli; Mark T Nelson; Joseph E Brayden
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

4.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

5.  Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes.

Authors:  Dacia L Hunton; Pamela A Lucchesi; Yi Pang; Xiaogang Cheng; Louis J Dell'Italia; Richard B Marchase
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

6.  G alpha(i) and G alpha(o) are target proteins of reactive oxygen species.

Authors:  M Nishida; Y Maruyama; R Tanaka; K Kontani; T Nagao; H Kurose
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

7.  A novel recombinant hyperaffinity inositol 1,4,5-trisphosphate (IP(3)) absorbent traps IP(3), resulting in specific inhibition of IP(3)-mediated calcium signaling.

Authors:  Tsuyoshi Uchiyama; Fumio Yoshikawa; Akira Hishida; Teiichi Furuichi; Katsuhiko Mikoshiba
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

8.  Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling.

Authors:  Erik W Bush; David B Hood; Philip J Papst; Joseph A Chapo; Wayne Minobe; Michael R Bristow; Eric N Olson; Timothy A McKinsey
Journal:  J Biol Chem       Date:  2006-09-01       Impact factor: 5.157

9.  Heteromultimeric TRPC6-TRPC7 channels contribute to arginine vasopressin-induced cation current of A7r5 vascular smooth muscle cells.

Authors:  Yoshiaki Maruyama; Yuko Nakanishi; Emma J Walsh; David P Wilson; Donald G Welsh; William C Cole
Journal:  Circ Res       Date:  2006-05-11       Impact factor: 17.367

10.  The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel.

Authors:  R Inoue; T Okada; H Onoue; Y Hara; S Shimizu; S Naitoh; Y Ito; Y Mori
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

View more
  156 in total

Review 1.  Canonical TRP channels and mechanotransduction: from physiology to disease states.

Authors:  Amanda Patel; Reza Sharif-Naeini; Joost R H Folgering; Delphine Bichet; Fabrice Duprat; Eric Honoré
Journal:  Pflugers Arch       Date:  2010-05-21       Impact factor: 3.657

Review 2.  Emerging concepts for the role of TRP channels in the cardiovascular system.

Authors:  Rudi Vennekens
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

3.  Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

Authors:  Tom Nijenhuis; Alexis J Sloan; Joost G J Hoenderop; Jan Flesche; Harry van Goor; Andreas D Kistler; Marinka Bakker; Rene J M Bindels; Rudolf A de Boer; Clemens C Möller; Inge Hamming; Gerjan Navis; Jack F M Wetzels; Jo H M Berden; Jochen Reiser; Christian Faul; Johan van der Vlag
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

Review 4.  From GTP and G proteins to TRPC channels: a personal account.

Authors:  Lutz Birnbaumer
Journal:  J Mol Med (Berl)       Date:  2015-09-16       Impact factor: 4.599

5.  Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.

Authors:  D Brian Foster; Ting Liu; Kai Kammers; Robert O'Meally; Ni Yang; Kyriakos N Papanicolaou; C Conover Talbot; Robert N Cole; Brian O'Rourke
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

6.  Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.

Authors:  Naohiro Yamaguchi; Asima Chakraborty; Daniel A Pasek; Jeffery D Molkentin; Gerhard Meissner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

7.  Ca2+ influx and protein scaffolding via TRPC3 sustain PKCbeta and ERK activation in B cells.

Authors:  Takuro Numaga; Motohiro Nishida; Shigeki Kiyonaka; Kenta Kato; Masahiro Katano; Emiko Mori; Tomohiro Kurosaki; Ryuji Inoue; Masaki Hikida; James W Putney; Yasuo Mori
Journal:  J Cell Sci       Date:  2010-02-23       Impact factor: 5.285

8.  Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.

Authors:  Motohiro Nishida; Kenta Watanabe; Yoji Sato; Michio Nakaya; Naoyuki Kitajima; Tomomi Ide; Ryuji Inoue; Hitoshi Kurose
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

Review 9.  Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Authors:  Deborah Peana; Timothy L Domeier
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

10.  Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.

Authors:  Jung Woo Han; Young Ho Lee; Su-In Yoen; Joel Abramowitz; Lutz Birnbaumer; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.